In order to continue supporting customers and partners as best as possible, at ZEISS we are doing everything we can to protect our employees’ health and safety as well as maintain production in our plants and ensure our service operations.
In January, ZEISS set up a dedicated task force. We are closely assessing the latest developments together with government agencies and healthcare authorities on an ongoing basis. Decisions are made daily regarding the most sensible measures for ZEISS to take.
Of course, we will continue to be available for our customers as best we can. Some employees in individual areas are currently working remotely but can still be reached at their usual phone numbers and email addresses.
However, should our customers experience any disruptions in service at some of our sites and sales offices, we can also be contacted on these numbers.
All over the world, the company and its employees are joining the fight against the spread and consequences of the coronavirus pandemic. Read more
31 March 2021
ZEISS, the leading global optics and optoelectronics technology company, has completed construction of its new R&D, production, sales and customer service site in the San Francisco Bay Area.
3 March 2021
The winners of the ZEISS Quantum Challenge 2020 have been chosen: Prof. Dr. Friedemann Reinhard, Professor of Quantum Technology at the University of Rostock, and Dr. Gabriel Puebla-Hellmann, CEO of QZabre AG in Zurich, impressed the expert judges with their ideas.
8 February 2021
Carl Zeiss Meditec generated revenue of €368.9m in the first three months of fiscal year 2020/21 (prior year: €369.7m), corresponding to a decline of just -0.2% (adjusted for currency effects: +2.6%) compared with the year-ago period, which had not yet been impacted by the COVID-19 pandemic. Earnings before interest and tax (EBIT) increased to €73.4m (prior year: €56.8m). The EBIT margin was 19.9% (prior year: 15.4%).